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Summary. Background and Objective. In Latvia, the mean age of women giving birth increased 
from 27.3 in 2000 to 29.0 years in 2010 during the last 11 years. The aim of this study was to report 
on major congenital anomalies of newborns at birth by the maternal age and to compare the mean 
maternal age by different diagnosis subgroups and maternal and neonatal characteristics. 
Material and Methods. A cross-sectional retrospective study with the data from the Medical 
Birth Register (2000–2010) was carried out. The live birth prevalence rate was calculated for the 
subgroups of major congenital anomalies per 10 000 live births by the maternal age. 
Results. The live birth prevalence rate of major congenital anomalies during the period 2000–
2010 was 211.4 per 10 000 live births. The prevalence rate increased depending on the maternal 
age. Congenital heart defects, limb defects, and urinary system anomalies were the most common 
anomalies. The study results showed an age-related risk of abdominal wall defects, orofacial clefts, 
and chromosomal anomalies. There were significantly higher proportions of preterm births, newborns 
with low birth weight, and complications during pregnancy among mothers aged 35 years and more. 
Conclusions. The data on congenital anomalies from the Latvian Medical Birth Register can be 
used for the assessment of epidemiology of congenital anomalies. The results of this retrospective 
study showed a decrease in the live birth prevalence rate of major congenital anomalies despite an 
increase in the mean age of mothers in Latvia.
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Introduction
A birth defect is typically defined as any abnor-
mality affecting the structure or function of the body 
that is present from birth (1–3). At least 7.9 mil-
lion people worldwide are born with a birth defect 
each year. An average of 3.3 million children un-
der 5 years of age die from birth defects each year, 
while an estimated 3.2 million of those who survive 
may have lifelong disability (1). In Latvia, an aver-
age of 25%–30% of all infant deaths are caused by 
congenital malformations (4). The perinatal, neo-
natal, and infant mortality rates in Latvia are quite 
high when compared with other European countries 
and are approximately 2 times higher than the aver-
age rate for the European Union (5). In Latvia, the 
mean age of women giving birth and of primiparas 
increased from 27.3 to 29.0 years and from 24.4 to 
26.4 years, respectively, over the last 11 years (2000 
vs. 2010) (6). The statistical data also show a slight 
increase in the proportion of live births in women 
aged 35 and more (from 12.9% in 2008 to 14.8% in 
2010) (4). Simultaneously, the overall prevalence of 
congenital anomalies at birth in Latvia decreased. 
Scientific literature has described the effect of the 
maternal age on the outcome of pregnancy as well 
as its relationship with newborn’s birth defects. 
Some birth defects such as chromosomal abnor-
malities (the most common being Down syndrome) 
or nonchromosomal abnormalities, such as cardiac 
defects, diaphragmatic hernia, hypospadias, and 
clubfoot, increase in prevalence with an increasing 
age of mothers, while other defects have a higher 
prevalence among younger mothers, including non-
chromosomal abnormalities, such as abdominal wall 
defects (omphalocele and gastroschisis), polydac-
tyly, anencephaly, and hydrocephaly (7–15). The 
aim of this study was to report on major congenital 
anomalies of newborns at birth by the maternal age 
and to compare the mean maternal age by differ-
ent diagnosis subgroups and maternal and neonatal 
characteristics. The main research issues were relat-
ed to the live birth prevalence of major congenital 
anomalies by the maternal age and to the age-relat-
ed risk for anomaly subgroups.
Material and Methods
A descriptive, cross-sectional, retrospective 
study was carried out using the data from the Medi-
cal Birth Register (MBR). The MBR is based on 
the information provided by cards issued for new-
borns by maternity units across the country. Of the 
233 601 total live births in Latvia between 2000 
and 2010, there were 7451 live newborns registered 
with congenital anomalies (International Classifica-
tion of Disease [ICD-10]; Q00–Q99) at birth. The 
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congenital anomalies included in the analyses were 
diagnosed by a neonatologist using ultrasound ex-
aminations and genetic testing. These investigations 
were performed during the time spent in a mater-
nity unit after delivery. 
The data analyzed include the following con-
genital anomaly subgroups: nervous (Q00, Q01, 
Q02, Q03, Q04, Q05, Q06, Q07); eye (Q10.0, 
Q10.4, Q10.6–Q10.7, Q11–Q15); ear, face, and 
neck (Q16, Q17.8, Q18.3, Q18.8); congenital heart 
defects (Q20–Q26); respiratory (Q30–Q34); orofa-
cial clefts (Q35–Q37); digestive system (Q38–Q39, 
Q40.2–Q40.9, Q41–Q45, Q79.0); abdominal wall 
defects (Q79.2, Q79.3, Q79.5); urinary (Q60–Q64, 
Q79.4); genital (Q50–Q52, Q54–56); limb (Q65.0–
Q65.2, Q65.8–Q65.9, Q66.0, Q68.1–Q68.2, Q68.8, 
Q69–Q74); musculoskeletal system (Q75.0–75.1, 
Q75.4–Q75.9, Q76.1–Q76.4, Q76.6–Q76.9, Q77, 
Q78, Q79.6–Q79.9); and other anomalies/syn-
dromes (Q27, Q28, Q80–Q85, Q89) and chromo-
somal anomalies (Q90–Q92, Q93, Q96–Q99). This 
classification of the subgroups is based on the Eu-
ropean Surveillance of Congenital Anomalies (EU-
ROCAT) methodology (16).
To describe the study population, we analyzed 
the different characteristics of mothers and new-
borns by the maternal age groups. Mothers were 
categorized by age into 3 groups: ≤19 years, 20 to 
34 years, and 35≥ years. The marital status was also 
considered in the analysis. Other variables analyzed 
included the data about antenatal care (if the mother 
had antenatal care or did not register for and did 
not receive antenatal care), parity (either primipara 
or multipara), mother’s diseases and complications 
during delivery and pregnancy, and a history of 
abortions due to medical reasons. For newborns, 
birth weight and gestational week were recorded 
and classified as either low (≤2499 g) or normal 
(≥2500 g) and preterm birth (22–36 weeks) or term 
birth (37–42 weeks), respectively.
The live birth prevalence rate (total and by 
maternal age) of major congenital anomalies per 
10 000 live births was calculated. Of all 7451 live 
newborns suffering from congenital anomalies at 
birth during 2000–2010, there were 4927 cases of 
major congenital anomalies. The distribution of 
major congenital anomaly subgroups by gender was 
also analyzed. Major congenital anomalies were de-
fined as lethal (if the defects cause stillbirth or infant 
death or pregnancies are terminated after a prenatal 
diagnosis) and severe (if the defects without medi-
cal intervention cause disability or death) defects 
together (17).
The data analysis was performed by SPSS for 
Windows (version 19). The chi-square test and lin-
ear regression were used for the data analysis. Odds 
ratios (OR) and 95% confidence intervals (CI) were 
computed to determine associations between ma-
ternal age and likelihood of having a newborn with 
a congenital anomaly. This study was approved by 
the Ethics Committee of Riga Stradins University 
(January 21, 2011).
Results
Trends in Live Birth Prevalence Rate of Congeni-
tal Anomalies. There were 4927 newborns with ma-
jor congenital anomalies diagnosed at birth during 
2000–2010, representing 2.1% of all live births dur-
ing 2000–2010. During the same period, the average 
live birth prevalence of major congenital anomalies 
was 211.40 per 10 000 (95% CI, 192.4–230.9). The 
prevalence rate decreased significantly from 204.8 
per 10 000 (95% CI, 185.5–225.6) in 2000 to 191.2 
per 10 000 (95% CI, 162.6–201.3) in 2010. With 
an average decrease of 5.2 (y=–5.2148x+243.17; 
R2=0.5292), the trend toward a decreasing preva-
lence by year was found to be significant (P<0.01) 
(Fig. 1). 
The most common anomalies (Table 1) in all the 
maternal age groups were congenital heart defects 
with a total live birth prevalence rate of 72.26 per 
10 000 live births (95% CI, 32.0–72.3), followed by 
limb defects at a rate of 41.23 per 10 000 (95% CI, 
31.8–41.2) and urinary system anomalies at a rate 
of 27.59 per 10 000 (95% CI, 26.0–29.7). The prev-
alence rate of limb defects decreased significantly 
(y=–1.0781x+12.207; R2=0.8609; P<0.001). 
Gender and Congenital Anomalies. The live birth 
prevalence rate of major congenital anomalies for 
boys was 229.6 per 10 000 and for girls 192.33 per 
10 000; the gender differences were statistically sig-
nificant (P<0.001).
There was a 2-fold higher prevalence rate for boys 
than girls in relation to urinary system anomalies, 
i.e., 36.1 per 10 000 (95% CI, 32.7–39.6) for boys 
compared with 18.7 per 10 000 (95% CI, 16.3–21.4) 
for girls (P<0.01). Boys also had an 8-fold higher 
rate for genital congenital anomalies (P<0.001) with 
Fig. 1. The prevalence rate of major congenital anomalies 
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Maternal Age and Congenital Anomalies of Newborns
a rate of 23.8 per 10 000 (95% CI, 21.1–26.8) for 
boys and 2.7 per 10 000 (95% CI, 1.9–3.9) for girls. 
However, girls had a slightly higher prevalence rate 
of congenital heart defects and limb defects than 
boys; however, these differences were not statisti-
cally significant. In the subgroups of other congeni-
tal anomalies, the prevalence rates were similar be-
tween both genders (Fig. 2.). 
Maternal Age and Congenital Anomalies. The live 
birth prevalence rate of major congenital anomalies 
EUROCAT Anomaly Subgroup ICD-10





Nervous Q00, Q01, Q02, Q03, Q04, Q05, Q06, Q07 9.23 7.81 9.00* 11.81*
Eye Q100, Q104, Q106–Q107, Q11–Q15 0.51 0.49 0.49 0.74
Ear, face, and neck Q16, Q178, Q183, Q188 1.29 0.98 1.35 1.11
Congenital heart defects Q20–Q26 72.26 37.10 75.48* 76.78*
Respiratory Q30–Q34 0.69 0.00 0.81 0.37
Orofacial clefts Q35–Q37 11.33 10.74 11.11 13.29
Digestive system Q38–Q39, Q402–Q409, Q41–Q45, Q790 9.78 3.91 9.92* 13.29*
Abdominal wall defects Q792, Q793, Q795 4.98 5.37 5.07 4.06
Urinary Q60–Q64, Q794 27.59 13.67 29.01* 28.42*
Genital Q50–Q52, Q54–Q56 13.52 10.25 13.16 18.46*
Limb Q650–Q652, Q658–Q659, Q660, Q681–Q682, Q688, Q69–Q74 41.23 18.55 43.29* 44.29*
Musculoskeletal system Q750–Q751, Q754–Q759, Q761–Q764, 
Q766–Q769, Q77, Q78, Q796–Q799 1.41 1.46 1.35 1.85
Other anomalies/syndromes Q27, Q28, Q80–Q85, Q89 10.08 0.49 0.54 0.74
Chromosomal Q90–Q92, Q93, Q96–Q99 8.92 3.91 5.82 33.96*
Total major congenital anomalies 
subgroups 211.40 118.13 214.48* 260.96*
Total congenital anomalies 
(incl. minor anomalies, excluded 
from EUROCAT subgroups)
Q00–Q99 319.71 176.22 330.50* 354.35*
*P<0.05 compared with mothers aged ≤19 years.
Table 1. Live Birth Prevalence Rates According to the Subgroups of Major Anomalies Registered 
in Medical Birth Register and Maternal Age in Latvia (2000–2010)
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in newborns increased with maternal age: 118.1 per 
10 000 (95% CI, 103.7–133.9) for mothers aged up 
to 19 years, 214.5 per 10 000 (95% CI, 195.5–235.0) 
for mothers aged 20–34 years, and 261.0 per 10 000 
(95%CI, 194.0–234.2) for mothers aged 35 years 
and more. The total prevalence rates significantly 
increased in the maternal age groups of 20–34 years 
old and 35 and older when compared with mothers 
aged up to 19 years (P<0.001) (Table 2). 
The mean age of all mothers having newborns 
with major congenital anomalies was 27.82 years 
(SD, 6.0). The mean maternal age differed by the di-
agnosis of congenital anomaly subgroups. Mothers 
having newborns with eye anomalies and abdomi-
nal wall defects were slightly younger (26.63 years 
[SD, 6.65] and 26.01 years [SD, 5.77], respectively). 
Significant differences in the mean age of moth-
ers having newborns with congenital anomalies by 
congenital anomalies subgroups were found: 33.36 
(SD, 5.29) with a difference of 5.54 years (95% CI, 
–5.76; –5.32) for teratogenic syndromes and 32.49 
(SD, 7.43) with a difference of 4.67 years (95% CI, 
–4.93; –4.40) for chromosomal anomalies.
The live birth prevalence rates were significantly 
higher in older maternal age groups for nervous, 
cardiac, digestive and urinary system, limb defects, 
and genital and chromosomal anomalies. 
Relationships Between Maternal Age and Congeni-
tal Anomalies. The study results showed an age-re-
lated risk of abdominal wall defects, orofacial clefts, 
and chromosomal anomalies. Mothers younger than 
20 years were more likely to have newborns with 
orofacial clefts (OR, 1.8; 95% CI 1.2–2.3; P<0.01), 
abdominal wall defects (OR, 1.97; 95% CI 1.2–3.5; 
P<0.05), and chromosomal abnormalities (OR, 2.4; 
95% CI 1.2–5.2; P<0.05) compared with mothers 
aged 20–34 years. Meanwhile, older mothers (35 
years and more) had a 3-fold greater likelihood of 
having a newborn with abdominal wall defects (OR, 
3.0; 95% CI, 1.2–7.6; P<0.01) in comparison with 
mothers younger than 20 years. Mothers aged 35 
years and more were 5 and 2 times more likely to 
have a newborn with chromosomal anomalies other 
than congenital anomalies than 20- to 34-year-old 
mothers (OR, 5.4; 95% CI, 4.0–7.2; P<0.001) and 
mothers younger than 20 years (OR, 2.2; 95% CI, 
1.1–5.1; P<0.05).
Differences in Characteristics of Mothers by Age 
Groups. There were differences in the percent-
age distribution of mothers having newborns with 
major congenital anomalies by maternal char-
acteristics and age groups (Table 2). There were 
differences between the maternal age groups by 
parity, where the largest proportion of primipa-
ras was found among mothers aged 19 years and 
less compared with 20- to 34-year-old mothers 
(χ2=111.37; P<0.001) and those aged 35 years and 
more (χ2=403.18; P<0.001). Mothers aged 20–34 
years (χ2=10.16; P<0.001) and aged 35 years and 
more (χ2=6.06; P<0.01) had complications during 
delivery more frequently than those aged up to 19 
years. A significantly higher proportion of preterm 
births (from 22 to 36 gestational week) (χ2=14.11; 
P<0.001), low birth weight of newborns (≤2499 g) 
(χ2=6.18; P<0.01), and complications during preg-
nancy (χ2=5.78; P<0.05) were among mothers aged 
35 years and more in comparison with mothers aged 
20–34 years.
Discussion
Congenital anomalies are one of the major caus-
es of pregnancy loss, stillbirth, neonatal death, and 
physical defects and disabilities around the world 
(1–3). The analysis of the data from the Medical 
Birth Register of Latvia showed that the live birth 
prevalence rate of major congenital anomalies in 
newborns increased with the maternal age. These 
findings are consistent with the results of other pub-
lished studies (7, 10–15). 
The mean maternal age has increased in Lat-
via in the past few decades (4, 6). In the United 
States, the number of first births per 1000 women 
aged 35 to 39 years increased by 36% between 1991 
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Table 2. Percentage Distribution of Mothers Having Newborns With Major Congenital Anomalies Diagnosed at Birth 
by Characteristics of Mothers and Their Newborns and Maternal Age (2000–2010)
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age increased, the prevalence of major congenital 
anomalies decreased between 2000 and 2010. A 
decreasing tendency in the total prevalence rate of 
congenital anomalies, also observed in the WHO 
and EUROCAT data, is mainly explained by better 
antenatal care and improved management of known 
risk factors, such as chronic maternal health condi-
tions (e.g., diabetes), and the reduction of health 
risk behaviors (e.g., smoking) (2, 5, 18). However, 
it should be mentioned that the EUROCAT total 
prevalence rates of congenital anomalies included 
the cases of live births, stillbirths, and terminations 
of pregnancy due to fetal anomalies (2).
The total and live birth prevalence of congenital 
anomalies could be higher in Latvia if cases of con-
genital anomalies detected in newborns aged up to 
1 year as well as the termination of pregnancy due 
to congenital anomalies were included. There is no 
information on cases diagnosed during the postneo-
natal period in the Medical Birth Register.
The aim of this study was to analyze only the 
live birth prevalence rate of congenital anomalies 
at birth. There is no comprehensive statistical in-
formation about the terminations of pregnancy due 
to congenital anomalies. In this regard, additional 
studies are needed in Latvia to determine the preva-
lence rates of the terminations of pregnancy due to 
different reasons, including birth defects.
The data from the Medical Birth Register of 
Latvia revealed that mothers who delivered babies 
with major congenital anomalies had an average age 
of 27.82 years, which was significantly greater (by 
more than 4 years) for mothers who had newborns 
with chromosomal anomalies (32.49 years). It cor-
responds to the results of other publications. The 
advancing maternal age increases the risk of cer-
tain chromosomal abnormalities, especially Down 
syndrome (1, 2, 12–15). According to the EURO-
CAT data, the live birth prevalence rate of Down 
syndrome for the 2000–2004 period was 9.65 per 
10 000 births (2). In Latvia, the live birth preva-
lence rates of chromosomal anomalies and Down 
syndrome were slightly lower, i.e., 8.92 and 7.98 per 
10 000, respectively. In England, the mean age of 
mothers of live born children with Down syndrome 
increased from 30.6 years in 1989/1990 to 34.4 
years in 2007/2008, while the mean age of moth-
ers of antenatally diagnosed cases decreased (15). 
In Latvia, the mean age of mothers of newborns 
with Down syndrome remained the same: 31.1 (SD, 
8.3) in 2000 and 31.5 (SD, 6.4) in 2010, with the 
mean  age of 33.0 years (SD, 7.4) during this period 
(2000–2010). 
Some publications have indicated that women 
aged 25 years and more at delivery had a signifi-
cantly greater risk of having fetuses with nonchro-
mosomal anomalies when compared with women 
aged between 20 and 24 years (10, 11). Very young 
mothers have an increased risk of adverse pregnancy 
outcomes. Studies have noted that teenage mothers 
more likely than older mothers belong to a lower 
socioeconomic group, are less educated, unmar-
ried, and are less likely to have early prenatal care 
(9). Multivitamin use is also lowest among pregnant 
women younger than 20 years (8). Studies have 
shown that a higher proportion of mothers in Latvia 
did not receive antenatal care. This was observed in 
both the groups of women younger than 20 years 
(5.0%) and aged 35 and more (6.2%). This could 
be explained by a larger proportion of unplanned 
pregnancies in those groups. 
The importance of antenatal care as a predictor 
of a favorable outcome of childbirth, including a re-
duced risk of low birth weight, premature births, 
and infant mortality, has been widely described in 
the literature (19–24). These results indicate that 
delayed antenatal care is a risk factor for the late 
neonatal diagnosis of congenital abnormalities. This 
interferes in some cases with an early termination of 
pregnancy due to medical reasons. An early detec-
tion of birth defects can ensure adequate maternity 
assistance in tertiary hospital maternity units and 
reduce health complications and premature death of 
a newborn.
There were associations between inadequate 
antenatal care and preterm deliveries, which were 
also more frequent in women younger than 19 years 
or older than 35 years. In fact, 10.3% of pregnan-
cies among mothers aged up to 19 years and 12.0% 
among mothers aged 20 to 34 years resulted in pre-
term deliveries. The distribution of mothers by par-
ity indicated that 90.5% of mothers younger than 
20 years were primiparas compared with 56.0% of 
mothers aged 20–34 years and 18.4% of mothers 
aged 35 years and more. The data are similar with 
the EUROCAT data, where primiparas made up 
80% of mothers aged up to 20 years, 55% of moth-
ers aged 20 to 24 years, and 46% of mothers aged 
25 to 29 years (23).
Congenital heart defects were the anomalies with 
the highest live birth prevalence rate during our 
study period (2000–2010). However, the prevalence 
rate in Latvia was quite similar to the average preva-
lence rate reported for Europe during 2000–2005 
(7.2 per 1000 births). Congenital heart defects ac-
count for nearly one-third of all major congenital 
anomalies diagnosed either prenatally or in infancy 
in Europe (23). In this study period (2000–2010), 
the live birth prevalence rate of congenital heart 
defects was 72.26 per 10 000. Vital statistical data 
show that family practitioners detected an average of 
0.3%–0.5% (2007–2010) of congenital heart diseas-
es in babies aged up to 1 year of all live births (24). 
In this study, the most common congenital heart 
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defects detected at birth were congenital malforma-
tions of cardiac septa (Q21; 50% of all heart defects, 
n=838). Persistent ductus arteriosus (Q21.1, PDA) 
and foramen ovale apertum (Q25.0) accounted for 
6.5% (n=110) and 10.9% (n=183) of all congenital 
heart defects (Q20–Q26), respectively. In literature, 
the reported incidence of PDA varies from 5% to 
10% of all congenital heart diseases (25). Premature 
newborns made up 8.5% (n=419) of all the study 
population, and premature live newborns with con-
genital heart defects accounted for 2.3% (n=113) 
of all newborns with major congenital anomalies 
or 6.7% of all newborns with congenital heart de-
fects. The proportion of premature newborns with 
PDA (n=7) and foramen ovale (n=8) was 4.4% of 
all newborns with anomalies in each group at birth. 
Other study reported that every third preterm infant 
with a very low birth weight of 501 to 1500 g could 
be expected to have a persistent PDA (26).
In the present study, mothers younger than 20 
years had a significantly increased risk of having 
a newborn with abdominal wall defects (OR, 3.0) 
when compared with mothers aged 35 years and 
more. These findings are consistent with the data 
of other studies. The data from the US have shown 
that the OR of gastroschisis was higher in newborns 
of mothers younger than 15 years and aged 16–19 
years (OR=1.21 and OR=1.68, respectively) when 
compared with the 20–24-year age group (10). The 
EUROCAT data show that the highest prevalence 
of all nonchromosomal anomalies was observed in 
babies of mothers younger than 20 years (11). 
The study from the United States estimated 
that different complications of pregnancy increased 
steadily with women’s age; one example is hyperten-
sive complications, which are twice as likely to occur 
in women aged 40 years or more when compared 
with younger women (8). Our study findings were 
similar: significantly higher proportions of preterm 
births, newborns with low birth weight, and com-
plications during pregnancy were found in mothers 
aged 35 years and more when compared with the 
20–34-year age group.
Clinical and public health interventions are 
needed to reduce risk factors, with special atten-
tion focused on younger mothers’ lifestyle factors 
and health education as well as other factors. For 
mothers of all ages, family planning, antenatal care, 
and improvements in examinations to detect con-
genital anomalies (initial screenings) are also very 
important.
One of the limitations to this study is that the 
MBR is difficult to be linked with other databases 
and registers in Latvia because the information in 
the MBR is based on the mother’s personal code; 
meanwhile, other databases are based on the in-
fant’s/child’s personal code. Each registry is located 
within a different information system, and each of 
them uses a different method to gather the data. 
Therefore, it is difficult to compare and analyze the 
data in a unified way. During the last years, many 
efforts have been made to set up and improve the 
process of data linkage in Latvia. Since 2010, the 
MBR is a part of the Register of Patients Suffering 
from Certain Diseases, which includes separate dif-
ferent registers (such as Diabetes Register, Register 
of Patients Suffering From Mental Diseases and Al-
cohol Abuse, Trauma Register, etc.). All these reg-
isters serve as separate units, but technically they are 
linked together into one data system. The process 
of online filling of medical documentation for the 
MBR and cooperation with hospitals and perinatal 
centers in order to include and validate congenital 
anomaly diagnoses of newborns after their discharge 
from the maternity unit is expected to start in 2013.
The MBR is based on the information provided 
by medical documentation (MBR cards), issued to 
a newborn by maternity units, and on the cases of 
congenital anomalies diagnosed during the stay in a 
maternity unit. Birth defects diagnosed later are not 
included in the MBR. The observation period for 
the detection of congenital anomalies usually de-
pends on the length of hospital stay after delivery.
Nevertheless, the MBR contains the information 
essential for epidemiological studies and surveys on 
perinatal health, including the data on all newborns 
and their characteristics. The benefit of research 
would increase if the data from the MBR were com-
bined with the data from other sources in the future. 
To date, there are no such large epidemiologi-
cal studies done on major congenital anomalies in 
Latvia. This type of data analysis provides better un-
derstanding of the problem of congenital anomalies 
from the perspective of the population and allows 
the detection of risk groups and risk factors dur-
ing pregnancy, at birth, and later during neonatal 
period. All the discovered risks can be used as the 
indicators of prevention and early detection of con-
genital anomalies.
These findings also underscore the importance 
of further research into the analysis of the associa-
tions between the maternal age and occurrence of 
congenital anomalies.
Conclusions
The data on congenital anomalies from the Lat-
vian Medical Birth Register have not been widely 
used before. However, this study shows that the 
MBR data may be useful for epidemiological stud-
ies on congenital anomalies in Latvia. All the results 
are consistent with similar results from the studies 
in other countries. The results of this 11-year ret-
rospective study showed a decreasing trend of the 
live birth prevalence of major congenital anomalies 
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in Latvia. However, the prevalence rates of the ma-
jority of congenital anomalies increase with mater-
nal age. Significantly higher proportions of preterm 
births, newborns with low birth weight, and compli-
cations during pregnancy were documented in the 
older maternal age groups.
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